From the Guidelines
Vitamin A is effective for treating measles in children, and the recommended dosage is 200,000 IU for children older than 1 year and 100,000 IU for infants, with a second dose given the next day, as supported by the most recent and highest quality study 1.
Key Points
- Vitamin A supplementation has been shown to reduce mortality and prevent complications such as pneumonia and diarrhea in children with measles 1.
- The World Health Organization recommends vitamin A supplementation for all children diagnosed with measles, particularly in areas where vitamin A deficiency or measles case-fatality rates are high 1.
- Vitamin A works by helping maintain epithelial tissue integrity and immune function, which are compromised during measles infection 1.
- A study published in 2020 in the journal Clinical Nutrition highlights the importance of vitamin A supplementation in reducing morbidity and mortality in infectious diseases, including measles 1.
Dosage and Administration
- The recommended dosage of vitamin A for children with measles is 200,000 IU for children older than 1 year and 100,000 IU for infants, with a second dose given the next day 1.
- Children with complicated measles should receive a second dose of vitamin A on day 2 1.
Benefits of Vitamin A Supplementation
- Reduces mortality and prevents complications such as pneumonia and diarrhea in children with measles 1.
- Helps maintain epithelial tissue integrity and immune function, which are compromised during measles infection 1.
- Reduces morbidity and mortality in infectious diseases, including measles, diarrhea, and malaria 1.
From the Research
Effectiveness of Vitamin A in Treating Measles in Children
- Vitamin A has been shown to be effective in reducing mortality and complications in children with measles, particularly when given in two doses of 200,000 IU on consecutive days 2, 3, 4.
- The World Health Organization (WHO) recommends administration of an oral dose of 200,000 IU (or 100,000 IU in infants) of vitamin A per day for two days to children with measles in areas where vitamin A deficiency may be present 2, 3, 4.
- Studies have found a significant reduction in mortality in children under the age of two years who received two doses of vitamin A (200,000 IU) on consecutive days, with a relative risk (RR) of 0.18 (95% CI 0.03 to 0.61) 2, 3, 4.
- Vitamin A has also been shown to reduce the incidence of croup (RR 0.53; 95% CI 0.29 to 0.89) and pneumonia-specific mortality (RR 0.33; 95% CI 0.08 to 0.92) in children with measles 2, 3, 4.
Dosage and Formulation
- Two doses of water-based vitamin A were associated with a greater reduction in mortality (RR 0.19; 95% CI 0.02 to 0.85) compared to two doses of oil-based preparation (RR 0.52; 95% CI 0.16 to 1.40) 2, 3.
- A single dose of 200,000 IU of vitamin A was not associated with a significant reduction in mortality in children with measles (RR 0.77; 95% CI 0.34 to 1.78) 2, 3, 4.
Age and Nutritional Status
- The effect of vitamin A was greater in children under the age of two years, with a significant reduction in mortality (RR 0.18; 95% CI 0.03 to 0.61) and pneumonia-specific mortality (RR 0.33; 95% CI 0.08 to 0.92) 2, 3, 4.
- Mortality was several times higher in marasmic children compared to better-nourished children, regardless of vitamin A supplementation 5.
Clinical Trials and Studies
- A randomized clinical trial found that vitamin A supplements reduced mortality in children with measles, particularly in those under the age of two years (p < 0.05) 5.
- A retrospective study of hospital records found that high-dose vitamin A therapy (400,000 IU) was associated with a shorter hospital stay, lower requirement for intensive care, and lower death rate in children hospitalized with measles 6.